Welcure Drugs & Pharmaceuticals
Welcure Drugs & Pharmaceuticals Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Welcure Drugs & Pharmaceuticals
Start SIPWelcure Drugs & Pharmaceuticals Investment Rating
-
Master Rating:
-
Welcure Drugs & Pharms. has an operating revenue of Rs. 0.17 Cr. on a trailing 12-month basis. An annual revenue growth of 118% is outstanding, Pre-tax margin of 0% needs improvement, ROE of 6% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. It is currently FORMING a base in its weekly chart and is trading around 11% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 14 which is a POOR score indicating inconsistency in earnings, a RS Rating of 18 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 111 indicates it belongs to a poor industry group of Medical-Biomed/Biotech and a Master Score of E is the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Profit Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Welcure Drugs & Pharmaceuticals Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 9
- Bearish Moving Average
- ___
- 7
- 20 Day
- ₹3.99
- 50 Day
- ₹3.95
- 100 Day
- ₹3.97
- 200 Day
- ₹4.29
- 20 Day
- ₹4.00
- 50 Day
- ₹3.93
- 100 Day
- ₹3.88
- 200 Day
- ₹3.97
Welcure Drugs & Pharmaceuticals Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 4.17 |
| Second Resistance | 4.26 |
| Third Resistance | 4.41 |
| RSI | 53.11 |
| MFI | 68.36 |
| MACD Single Line | 0.02 |
| MACD | 0.02 |
| Support | |
|---|---|
| First Resistance | 3.93 |
| Second Resistance | 3.78 |
| Third Resistance | 3.69 |
Welcure Drugs & Pharmaceuticals Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 88,991 | 8,405,200 | 94.45 |
| Week | 33,158 | 3,137,078 | 94.61 |
| 1 Month | 24,788 | 2,291,425 | 92.44 |
| 6 Month | 32,049 | 2,717,788 | 84.8 |
Welcure Drugs & Pharmaceuticals Result Highlights
Welcure Drugs & Pharmaceuticals Synopsis
BSE-Medical-Biomed/Biotech
Welcure Drugs & is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company’s Total Operating Revenue is Rs. 0.00 Cr. and Equity Capital is Rs. 13.44 Cr. for the Year ended 31/03/2023. Welcure Drugs & Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 06/08/1996 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L24232DL1996PLC227773 and registration number is 227773.| Market Cap | 5 |
| Sales | |
| Shares in Float | 1.35 |
| No of funds | |
| Yield |
| Book Value | 3.6 |
| U/D Vol ratio | 0.9 |
| LTDebt / Equity | |
| Alpha | -0.07 |
| Beta | 0.4 |
Welcure Drugs & Pharmaceuticals
| Owner Name | Sep-23 | Jun-23 | Mar-23 | Dec-22 |
|---|---|---|---|---|
| Promoters | ||||
| Financial Institutions/ Banks | 0.01% | 0.01% | ||
| Individual Investors | 94.29% | 93.67% | 93.65% | 93.73% |
| Others | 5.71% | 6.33% | 6.34% | 6.26% |
Welcure Drugs & Pharmaceuticals Management
| Name | Designation |
|---|---|
| Mr. Dharam Chand Jain | Non Executive Director |
| Mr. Murari Lal Bhateja | Independent Director |
| Mr. Gagan Juneja | Independent Director |
| Ms. Mitashi Bisaria | Non Executive Director |
| Mr. Mayank Bhandari | Ind. Non-Executive Director |
| Mr. Vishal Mehra | Chairman & Managing Director |
Welcure Drugs & Pharmaceuticals Forecast
Price Estimates
Welcure Drugs & Pharmaceuticals Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2023-11-14 | Quarterly Results | |
| 2023-08-14 | Quarterly Results | |
| 2023-07-11 | Quarterly Results | |
| 2023-05-29 | Audited Results | |
| 2023-02-14 | Quarterly Results | (Revised) |
Welcure Drugs & Pharmaceuticals FAQs
What is Share Price of Welcure Drugs & Pharmaceuticals ?
Welcure Drugs & Pharmaceuticals share price is ₹4 As on 08 December, 2023 | 12:04
What is the Market Cap of Welcure Drugs & Pharmaceuticals ?
The Market Cap of Welcure Drugs & Pharmaceuticals is ₹5.4 Cr As on 08 December, 2023 | 12:04
What is the P/E ratio of Welcure Drugs & Pharmaceuticals ?
The P/E ratio of Welcure Drugs & Pharmaceuticals is 148.8 As on 08 December, 2023 | 12:04
What is the PB ratio of Welcure Drugs & Pharmaceuticals ?
The PB ratio of Welcure Drugs & Pharmaceuticals is 3.6 As on 08 December, 2023 | 12:04